In contrast to knockdown or knockout of RSK2, overexpression of constitutive active RSK2 (CA-RSK2) enhanced the FOXO4 transactivation activity approximately 15 fold compared to that of mock expression in B16F10 mouse melanoma cells (Fig. 6C). The gene discussed is FOXO4; the disease is melanoma.